BIOMERIEUX – Group report and key figures

WHAT IS THE GROUP'S FINANCIAL SITUATION ?

The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.

WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?

Extend leadership positions in key markets through external growth

Sustain expansive innovation footprint and investment

Enhance service integration to develop a comprehensive offering

WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?

Through a SWOT analysis, this report also provides an overview of the group's strengths (solid financial position facilitates investments to grow production footprint and engage in M&A activities, etc.) and weaknesses (smaller in size compared to major European and American rivals, etc.).

1. Overview

Presentation

Segments

SWOT

2. Corporate Strategies and Recent Events

3. Financial Indicators

4. Statistical Appendix

5. Glossary